Donald D. Smyth

675 total citations
45 papers, 573 citations indexed

About

Donald D. Smyth is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Donald D. Smyth has authored 45 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Donald D. Smyth's work include Receptor Mechanisms and Signaling (19 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Nitric Oxide and Endothelin Effects (6 papers). Donald D. Smyth is often cited by papers focused on Receptor Mechanisms and Signaling (19 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Nitric Oxide and Endothelin Effects (6 papers). Donald D. Smyth collaborates with scholars based in Canada, United States and Japan. Donald D. Smyth's co-authors include S. Brian Penner, Satoshi Umemura, William A. Pettinger, Zhi Ming, W. Wayne Lautt, Daniel Sitar, John K. McKenzie, Gary B. Glavin, Fred Y. Aoki and Brian Penner and has published in prestigious journals such as Hepatology, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

Donald D. Smyth

45 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald D. Smyth Canada 16 230 145 130 95 67 45 573
D D Smyth Canada 17 366 1.6× 186 1.3× 142 1.1× 101 1.1× 88 1.3× 37 665
Khodadad Namiranian Iran 15 169 0.7× 201 1.4× 79 0.6× 178 1.9× 22 0.3× 32 643
P M Kabra United States 20 305 1.3× 65 0.4× 129 1.0× 125 1.3× 180 2.7× 33 1.1k
R. A. Ferrone United States 12 140 0.6× 69 0.5× 188 1.4× 94 1.0× 82 1.2× 13 498
V. R. Preedy United Kingdom 15 217 0.9× 58 0.4× 100 0.8× 202 2.1× 40 0.6× 53 727
Yasuharu Aki Japan 14 141 0.6× 82 0.6× 148 1.1× 139 1.5× 71 1.1× 35 506
Mahmoud M. Mohy El‐Din Egypt 13 153 0.7× 67 0.5× 125 1.0× 103 1.1× 79 1.2× 29 532
Peter C. Rubin United Kingdom 16 94 0.4× 55 0.4× 258 2.0× 78 0.8× 89 1.3× 48 868
M. R. Lee United Kingdom 10 184 0.8× 56 0.4× 145 1.1× 97 1.0× 120 1.8× 19 599
C Richer France 16 231 1.0× 86 0.6× 395 3.0× 117 1.2× 119 1.8× 46 737

Countries citing papers authored by Donald D. Smyth

Since Specialization
Citations

This map shows the geographic impact of Donald D. Smyth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald D. Smyth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald D. Smyth more than expected).

Fields of papers citing papers by Donald D. Smyth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald D. Smyth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald D. Smyth. The network helps show where Donald D. Smyth may publish in the future.

Co-authorship network of co-authors of Donald D. Smyth

This figure shows the co-authorship network connecting the top 25 collaborators of Donald D. Smyth. A scholar is included among the top collaborators of Donald D. Smyth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald D. Smyth. Donald D. Smyth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smyth, Donald D. & S. Brian Penner. (1999). Peripheral and Central Imidazoline Receptor‐Mediated Natriuresis in the Rata. Annals of the New York Academy of Sciences. 881(1). 344–357. 14 indexed citations
2.
Junaid, Asad, Cui Li, S. Brian Penner, & Donald D. Smyth. (1999). Regulation of Aquaporin-2 Expression by the α2-Adrenoceptor Agonist Clonidine in the Rat. Journal of Pharmacology and Experimental Therapeutics. 291(2). 920–923. 7 indexed citations
3.
Penner, Brian & Donald D. Smyth. (1996). IMatriuresis following Central and Peripheral Administration of Agmatine in the Rat. Pharmacology. 53(3). 160–169. 20 indexed citations
4.
Allan, Donald R., S. Brian Penner, & Donald D. Smyth. (1996). Antagonism by idazoxan at low dose but not high dose, of the natriuretic action of moxonidine. British Journal of Pharmacology. 117(1). 29–34. 3 indexed citations
5.
Glavin, Gary B. & Donald D. Smyth. (1995). Effects of the selective I1 imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in rats. British Journal of Pharmacology. 114(4). 751–754. 20 indexed citations
6.
Penner, S. Brian & Donald D. Smyth. (1995). The role of the peripheral sympathetic nervous system in the natriuresis following central administration of an I1imidazoline agonist, moxonidine. British Journal of Pharmacology. 116(6). 2631–2636. 17 indexed citations
7.
Smyth, Donald D. & S. Brian Penner. (1995). Renal I1-Imidazoline Receptor-Selective Compounds Mediate Natnuresis in the Rat. Journal of Cardiovascular Pharmacology. 26(2). S63–S63. 11 indexed citations
8.
Li, Ping, S. Brian Penner, & Donald D. Smyth. (1994). Attenuated renal response to moxonidine and rilmenidine in one kidney‐one clip hypertensive rats. British Journal of Pharmacology. 112(1). 200–206. 20 indexed citations
9.
Penner, S. Brian & Donald D. Smyth. (1994). Central and renal I1 imidazoline preferring receptors: Two unique sites mediating natriuresis in the rat. Cardiovascular Drugs and Therapy. 8(S1). 43–48. 15 indexed citations
10.
Penner, S. Brian & Donald D. Smyth. (1994). Sodium excretion following central administration of an I1 imidazoline receptor agonist, moxonidine. British Journal of Pharmacology. 112(4). 1089–1094. 27 indexed citations
11.
Penner, S. Brian, et al.. (1993). Selective Alpha‐1 Adrenoceptor Blockade and Renal Sodium Handling in Humans. The Journal of Clinical Pharmacology. 33(11). 1110–1115. 2 indexed citations
12.
Li, Ping & Donald D. Smyth. (1993). Decreased renal activity of vasopressin in spontaneously hypertensive rats. Journal of Hypertension. 11(1). 41–48. 10 indexed citations
13.
Sitar, Daniel, et al.. (1993). Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidine. Clinical Pharmacology & Therapeutics. 54(1). 23–27. 53 indexed citations
14.
Smyth, Donald D., et al.. (1991). Proximal Tubular α2-Adrenoceptor Density in the Spontaneously Hypertensive Rat. American Journal of Hypertension. 4(1_Pt_1). 64–67. 8 indexed citations
15.
Smyth, Donald D., et al.. (1989). Enhanced natriuretic potency of intravenous clonidine: extrarenal site of action?. European Journal of Pharmacology. 174(2-3). 181–188. 5 indexed citations
16.
Smyth, Donald D., et al.. (1989). Effects of central and peripheral neuropeptide Y on sodium and water excretion in the rat. Physiology & Behavior. 46(1). 9–11. 6 indexed citations
17.
Smyth, Donald D., et al.. (1988). Renal α2-adrenoceptor blockade decreases sodium and water excretion in the anesthetized rat. European Journal of Pharmacology. 154(2). 117–124. 9 indexed citations
18.
Penner, S. Brian & Donald D. Smyth. (1988). Chronic prazosin attenuates the natriuretic response to a modest saline load in anaesthetized rats. British Journal of Pharmacology. 93(2). 446–452. 5 indexed citations
19.
Smyth, Donald D., et al.. (1988). Disparate effects of neuropeptide Y and clonidine on the excretion of sodium and water in the rat. European Journal of Pharmacology. 152(1-2). 157–162. 19 indexed citations
20.
Pettinger, William A., Satoshi Umemura, & Donald D. Smyth. (1985). The Role of Renal Catecholamines in Hypertension. American Journal of Kidney Diseases. 5(4). A23–A26. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026